TY - JOUR
T1 - Renal replacement therapy in Europe
T2 - A summary of the 2013 ERA-EDTA Registry Annual Report with a focus on diabetes mellitus
AU - European Renal Association–European Dialysis and Transplant Association (ERA-EDTA)
AU - Kramer, Anneke
AU - Pippias, Maria
AU - Stel, Vianda S.
AU - Bonthuis, Marjolein
AU - Diez, José Maria Abad
AU - Afentakis, Nikolaos
AU - De La Torre, Ramón Alonso
AU - Ambuhl, Patrice
AU - Bikbov, Boris
AU - Caamaño, Encarnación Bouzas
AU - Bubic, Ivan
AU - Buturovic-Ponikvar, Jadranka
AU - Caskey, Fergus J.
AU - De La Nuez, Pablo Castro
AU - Cernevskis, Harijs
AU - Collart, Frederic
AU - Farnés, Jordi Comas
AU - Garcia Bazaga, Maria De Los Ángeles
AU - De Meester, Johan
AU - Alamar, Manuel Ferrer
AU - Finne, Patrik
AU - Garneata, Liliana
AU - Golan, Eliezer
AU - Heaf, James G.
AU - Hemmelder, Marc
AU - Ioannou, Kyriakos
AU - Kantaria, Nino
AU - Kolesnyk, Mykola
AU - Kramar, Reinhard
AU - Lassalle, Mathilde
AU - Lezaic, Visnja
AU - Lopot, Frantisek
AU - MacÁrio, Fernando
AU - Magaz, Angela
AU - Martín-Escobar, Eduardo
AU - Metcalfe, Wendy
AU - Ots-Rosenberg, Mai
AU - Palsson, Runolfur
AU - Celestino, Celestino Piñera
AU - Resic, Halima
AU - Rutkowski, Boleslaw
AU - De Pablos, Carmen Santiuste
AU - Spustová, Viera
AU - Stendahl, Maria
AU - Strakosha, Ariana
AU - Süleymanlar, Gültekin
AU - Guinea, Marta Torres
AU - Reisæter, Anna Varberg
AU - Vazelov, Evgueniy
AU - Ziginskiene, Edita
N1 - Publisher Copyright:
© The Author 2016. Published by Oxford University Press on behalf of ERA-EDTA.
PY - 2016/6
Y1 - 2016/6
N2 - Background: This article provides a summary of the 2013 European Renal Association-European Dialysis and Transplant Association (ERA-EDTA) Registry Annual Report (available at http://www.era-edta-reg.org), with a focus on patients with diabetes mellitus (DM) as the cause of end-stage renal disease (ESRD). Methods: In 2015, the ERA-EDTA Registry received data on renal replacement therapy (RRT) for ESRD from 49 national or regional renal registries in 34 countries in Europe and bordering the Mediterranean Sea. Individual patient datawere provided by 31 registries, while 18 registries provided aggregated data. The total population covered by the participating registries comprised 650 million people. Results: In total, 72 933 patients started RRT for ESRD within the countries and regions reporting to the ERA-EDTA Registry, resulting in an overall incidence of 112 per million population (pmp). The overall prevalence on 31 December 2013was 738 pmp (n = 478 990). Patients with DM as the cause of ESRD comprised 24% of the incident RRT patients (26 pmp) and 17% of the prevalent RRT patients (122 pmp).Whencompared with the USA, the incidence of patients starting RRTpmpsecondary toDMin Europe was five times lower and the incidence of RRT due to other causes of ESRD was two times lower. Overall, 19 426 kidney transplants were performed (30 pmp). The 5-year adjusted survival for all RRT patients was 60.9% [95% confidence interval (CI) 60.5-61.3] and 50.6% (95% CI 49.9-51.2) for patients with DM as the cause of ESRD.
AB - Background: This article provides a summary of the 2013 European Renal Association-European Dialysis and Transplant Association (ERA-EDTA) Registry Annual Report (available at http://www.era-edta-reg.org), with a focus on patients with diabetes mellitus (DM) as the cause of end-stage renal disease (ESRD). Methods: In 2015, the ERA-EDTA Registry received data on renal replacement therapy (RRT) for ESRD from 49 national or regional renal registries in 34 countries in Europe and bordering the Mediterranean Sea. Individual patient datawere provided by 31 registries, while 18 registries provided aggregated data. The total population covered by the participating registries comprised 650 million people. Results: In total, 72 933 patients started RRT for ESRD within the countries and regions reporting to the ERA-EDTA Registry, resulting in an overall incidence of 112 per million population (pmp). The overall prevalence on 31 December 2013was 738 pmp (n = 478 990). Patients with DM as the cause of ESRD comprised 24% of the incident RRT patients (26 pmp) and 17% of the prevalent RRT patients (122 pmp).Whencompared with the USA, the incidence of patients starting RRTpmpsecondary toDMin Europe was five times lower and the incidence of RRT due to other causes of ESRD was two times lower. Overall, 19 426 kidney transplants were performed (30 pmp). The 5-year adjusted survival for all RRT patients was 60.9% [95% confidence interval (CI) 60.5-61.3] and 50.6% (95% CI 49.9-51.2) for patients with DM as the cause of ESRD.
KW - End-stage renal disease
KW - Incidence
KW - Prevalence
KW - Renal replacement therapy
KW - Survival
UR - http://www.scopus.com/inward/record.url?scp=84979025531&partnerID=8YFLogxK
U2 - 10.1093/ckj/sfv151
DO - 10.1093/ckj/sfv151
M3 - Article
AN - SCOPUS:84979025531
SN - 2048-8505
VL - 9
SP - 457
EP - 469
JO - Clinical Kidney Journal
JF - Clinical Kidney Journal
IS - 3
ER -